| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
302.23(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
459,004 |
540,416 |
831,596 |
| Total Sell Value |
$0 |
$81,195,771 |
$93,320,391 |
$138,453,569 |
| Total People Sold |
0 |
9 |
9 |
12 |
| Total Sell Transactions |
0 |
10 |
13 |
29 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hurwich Thomas A. |
VP, Controller |
• – – |
2013-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
17,440 |
52,874 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2013-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
56,700 |
146,828 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• – – |
2013-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
257,720 |
307,152 |
|
- |
|
| Richmond Timothy J. |
SVP, Human Resources |
• – – |
2013-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
42,610 |
91,659 |
|
- |
|
| Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
– – – |
2013-02-07 |
4 |
D |
$37.14 |
$128,727 |
D/D |
(3,466) |
208,095 |
|
- |
|
| Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
– – – |
2013-02-07 |
4 |
OE |
$32.47 |
$122,617 |
D/D |
3,776 |
211,561 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2013-02-07 |
4 |
D |
$37.14 |
$155,542 |
D/D |
(4,188) |
90,128 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2013-02-07 |
4 |
OE |
$32.00 |
$147,074 |
D/D |
4,567 |
94,316 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2013-02-05 |
4 |
D |
$37.28 |
$86,676 |
D/D |
(2,325) |
112,921 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2013-02-05 |
4 |
OE |
$33.80 |
$83,887 |
D/D |
2,482 |
115,246 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2013-02-04 |
4 |
D |
$37.18 |
$238,956 |
D/D |
(6,427) |
25,188 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2013-02-04 |
4 |
OE |
$29.40 |
$221,097 |
D/D |
7,223 |
31,615 |
|
- |
|
| Waddell Frederick H |
Director |
– • – |
2013-02-04 |
4 |
B |
$37.05 |
$74,091 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| Abbott Laboratories |
10% Owner |
– – • |
2012-12-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(101) |
0 |
|
- |
|
| Abbott Laboratories |
10% Owner |
– – • |
2012-12-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
101 |
|
- |
|
765 Records found
|
|
Page 31 of 31 |
|
|
1.99 (1.15%) 
